Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Catolica, Santiago-Chile using revised EORTC/MSG diagnostic criteria;Enfermedad f́ngica invasora en pacientes hemato-oncológicos y receptores de trasplante de precursores hematopoyéticos bajo la perspectiva de los criterios diagnósticos EORTC/MSG

Revista Chilena de Infectologia

Volumn 26, Issue 3, 2009, Pages 212-219

  Rabagliati B , Ricardo ^a   Fuentes L , Gino ^b   Guzmán D , Ana María ^c   Orellana U , Eric ^c   Oporto C , Jorge ^b   Aedo C , Igor ^b   Garrido S , Marcelo ^c   Nervi N , Bruno ^c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cancer; Chemotherapy complications; Etiology; Febrile neutropenia; Hematopoietic stem cell transplantation; Mycoses

Indexed keywords

ADULT; ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOCOMPROMISED PATIENT; LEUKEMIA; LYMPHOMA; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOSIS;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MYCOSES;

EID: 67849127203     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolongued neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-10.
2. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-906.
3. Pazos C, Ponton J, Del Palacio A. Contribution of (1→3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43: 299-305.
4. Caillot D, Couaillier J F, Bernard A, Casasnovas O, Denning D W, Mannone L, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-9.
5. Ascioglu S, Rex J H, de Pauw B, Bennett J E, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An International Consensus. Clin Infect Dis 2002; 34: 7-14.
6. De Pauw B, Walsh, T J, Donnelly P, Stevens D A, Edwards J E, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
7. Walsh T J, Hiemens J W, Anaissie E. Recent progress and current problems in treatment of invasive fungal infection in neutropenic patients. Infect Dis Clin North Am 1996; 10: 365-400.
8. Lin S J, Schranz J, Teutsch S H. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
9. Nucci M, Marr K. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521-6.
10. Zaoutis T E, Heydon K, Chu J H, Walsh T J, Steinbach W J. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006; 117: e711-6.
11. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91: 1068-75.
12. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Cur Opin Infect Dis 2003; 16: 607-12.
13. Marr K, Carter R, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-17.
14. Santolaya M E, Rabagliati R, Bidart T, Paya E, Guzmán A M, Morales R, et al. Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre. Rev Chil Infect 2005, 22: S79-113.
15. Lucero Y, Brücher R, Álvarez A M, Becker A, Cofré J, Enríquez N, et al. Invasive fungal infections in children with cancer, neutropenia and fever, in Chile. Rev Méd Chile 2002; 130: 1139-46.
16. Marr K, Bowden R A. Fungal infection in patient undergoing blood and marrow transplantation. Transpl Infect Dis 1999; 1: 237-46.
17. Pagano L, Caira M, Nosari A, Van Lint M T, Candoni A, Offidani M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45: 1161-70.
18. Sung L, Lange B J, Gerbing R B, Alonzo T A, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 2007; 110: 3532-9.
19. Singh N, Paterson D L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44-69.
20. Chamilos G, Luna M, Lewis R E, Bodey G P. Chemaly R, Tarrand J J, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-9.
21. Anttila V J, Ruutu P, Bondestam S, Jansson S E, Nordling S, Färkkilä M, et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problema. Clin Infect Dis 1994; 18: 979-81.
22. Donahue S P, Greven C M, Zuravleff J J, Eller A W, Nguyen M H, Peacock J E Jr, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophtalmology 1994; 101: 1302-9
23. Karthaus K, Huebner G, Elser C, Geissler R G, Heil G, Ganser A. Early detection of chronic disseminated candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation. Ann Hematol 1998; 77: 41-5.
24. Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum 13d-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46: 1864-70.
25. Ellepola A N, Morrison C J. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005; 43: 65-84.
26. Moreira-Oliveira M S, Mikami Y, Miyaji M, Imai T, Schreiber A Z, Moretti M L. Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia. Eur J Clin Microbiol Infect Dis 2005; 24: 721-6.
27. Marr K, Seidel K, White T C, Bowden R A. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309-16.
28. Latge J P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
29. Marr K, Carter R A, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-66.
30. Richardson M D. Changing patterns and trends in systemic fungal infections. 2005; 56 Suppl 1: i5-i11.
31. Anaissie E J, Rex J H, Uzun O, Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998; 104: 238-45.
32. Chayakulkeeree M, Ghannoum M A, Perfect J R. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microb Inf Dis 2006; 25: 215-29.
33. Goodman J L, Winston D J, Greenfield R A, Chandrasekar P H, Fox B, Kaizer H, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-51.
34. Bow E J, Laverdière M, Lussier N, Rotstein C, Cheang M S, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002; 94: 3230-46.
35. Nucci M, Biasoli I, Akiti T, Silveira F, Solza C, Barreiros G, et al. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients. Clin Infect Dis 2000; 30: 300-5.
36. Marr K, Crippa F, Leisenring W, Hoyle M, Boeckh M, Balajee S A, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004; 103: 1527-33.
37. Uhlenbrock S, Zimmermann M, Fegeler W, Jürgens H. Ritter J. Liposomal amphotericin B for prophylaxis of invasive fungal infections in high-risk paediatric patients with chemotherapy-related neutropenia: interim analysis of a prospective study. Mycoses 2001; 44: 455-63.
38. Siwek G T, Pfaller M A, Polgreen P M, Cobb S, Hoth P, Magalhaes-Silverman M, et al. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microb and Infect Dis 2006; 55: 209-12.
39. Mattiuzzi G N, Alvarado G N, Giles F J, Ostrozky-Zeichner L, Cortés J, O'Brien S, et al. Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies. Antimicrob Agents Chemother 2006; 50 (1): 143-7.
40. van Burik J A, Ratanatharathorn V, Stepan D E, Miller C B, Lipton J H, Vesole D H, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infec Dis 2004; 39: 1407-16.
41. Cornely O A, Maertens J, Winston D J, Perfect J, Ullman A J, Walsh T J, et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-59.
42. Ullman A J, Lipton J H, Vesole D H, Chandrasekar P, Langston A, Tarantolo S R, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-47.
43. Siwek G T, Dodgson K J, de Magalhaes-Silverman M, Bartelt L A, Kilborn S B, Hoth P L, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584-7.
44. Pizzo P A, Robichaud K J, Gill F A, Witebsky F G. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101-11.
45. Walsh T J, Teppler H, Donowitz G R, Maertens J A, Baden L R, Dmoszynska A, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391-402.
46. Walsh T J, Pappas P, Winston D J, Lazarus H M, Petersen F, Raffalli J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-34.
47. Klastersky J. Antifungal therapy in patients with fever and neutropenia-more rational and less empirical? N Engl J Med 2004; 351: 1445-7.